EPCAM and neoplasm: However, it was suggested that, even if EpCAM low-expressing CTCs may be prognostically less relevant than EpCAM high-expressing CTCs, they could be used as a valuable tumour surrogate material and may have particular benefit if no CTCs are detected using EpCAM-dependent technologies [28].